220 related articles for article (PubMed ID: 29279288)
1. Systemic sclerosis complicated with localized scleroderma-like lesions induced by Köbner phenomenon.
Saigusa R; Asano Y; Yamashita T; Takahashi T; Nakamura K; Miura S; Ichimura Y; Toyama T; Taniguchi T; Sumida H; Tamaki Z; Miyazaki M; Yoshizaki A; Sato S
J Dermatol Sci; 2018 Mar; 89(3):282-289. PubMed ID: 29279288
[TBL] [Abstract][Full Text] [Related]
2. Dermal mast cells in scleroderma: their skin density, tryptase/chymase phenotypes and degranulation.
Akimoto S; Ishikawa O; Igarashi Y; Kurosawa M; Miyachi Y
Br J Dermatol; 1998 Mar; 138(3):399-406. PubMed ID: 9580789
[TBL] [Abstract][Full Text] [Related]
3. Clinical and laboratory features of systemic sclerosis complicated with localized scleroderma.
Toki S; Motegi S; Yamada K; Uchiyama A; Kanai S; Yamanaka M; Ishikawa O
J Dermatol; 2015 Mar; 42(3):283-7. PubMed ID: 25582037
[TBL] [Abstract][Full Text] [Related]
4. Localized scleroderma-like lesions induced by the Köbner phenomenon in a patient with systemic sclerosis positive for anticentromere antibody.
Asano Y; Sato S
Eur J Dermatol; 2020 Aug; 30(4):431-432. PubMed ID: 32808595
[No Abstract] [Full Text] [Related]
5. [Scleroderma].
Scharffetter K; Kind P; Wollny-Protzel D; Schuppe HC; Lakomek HJ; Goerz G
Z Hautkr; 1990 Mar; 65(3):237-42, 245-6. PubMed ID: 2187309
[TBL] [Abstract][Full Text] [Related]
6. Dermal mast cell density in fingers reflects severity of skin sclerosis in systemic sclerosis.
Yukawa S; Yamaoka K; Sawamukai N; Shimajiri S; Kubo S; Miyagawa I; Sonomoto K; Saito K; Tanaka Y
Mod Rheumatol; 2013 Nov; 23(6):1151-7. PubMed ID: 23271169
[TBL] [Abstract][Full Text] [Related]
7. Progranulin overproduction due to constitutively activated c-Abl/PKC-δ/Fli1 pathway contributes to the resistance of dermal fibroblasts to the anti-fibrotic effect of tumor necrosis factor-α in localized scleroderma.
Miyagawa T; Ichimura Y; Nakamura K; Hirabayashi M; Yamashita T; Saigusa R; Miura S; Takahashi T; Toyama T; Taniguchi T; Akamata K; Yoshizaki A; Sato S; Asano Y
J Dermatol Sci; 2018 Nov; 92(2):207-214. PubMed ID: 30268392
[TBL] [Abstract][Full Text] [Related]
8. [Role of Wnt 2, Wnt 3a and β-catenin in skin lesions of patients with scleroderma].
Liu J; Liu T
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1781-6. PubMed ID: 23268410
[TBL] [Abstract][Full Text] [Related]
9. Dermal mast cell degranulation in systemic sclerosis.
Seibold JR; Giorno RC; Claman HN
Arthritis Rheum; 1990 Nov; 33(11):1702-9. PubMed ID: 2242067
[TBL] [Abstract][Full Text] [Related]
10. Coexistence of morphea and systemic sclerosis.
Soma Y; Tamaki T; Kikuchi K; Abe M; Igarashi A; Takehara K; Ishibashi Y
Dermatology; 1993; 186(2):103-5. PubMed ID: 8428037
[TBL] [Abstract][Full Text] [Related]
11. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
[TBL] [Abstract][Full Text] [Related]
12. Mast cell numbers in diffuse scleroderma.
Nishioka K; Kobayashi Y; Katayama I; Takijiri C
Arch Dermatol; 1987 Feb; 123(2):205-8. PubMed ID: 3813593
[TBL] [Abstract][Full Text] [Related]
13. The downregulation of microRNA let-7a contributes to the excessive expression of type I collagen in systemic and localized scleroderma.
Makino K; Jinnin M; Hirano A; Yamane K; Eto M; Kusano T; Honda N; Kajihara I; Makino T; Sakai K; Masuguchi S; Fukushima S; Ihn H
J Immunol; 2013 Apr; 190(8):3905-15. PubMed ID: 23509348
[TBL] [Abstract][Full Text] [Related]
14. Abnormal expression of interleukin-6 is associated with epidermal alternations in localized scleroderma.
Zhu X; Jiang L; Zhong Q; Kong X; Zhang R; Zhu L; Liu Q; Wu W; Tan Y; Wang J; Xia J
Clin Rheumatol; 2022 Jul; 41(7):2179-2187. PubMed ID: 35277778
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma.
Tomimura S; Ogawa F; Iwata Y; Komura K; Hara T; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
J Dermatol Sci; 2008 Oct; 52(1):47-54. PubMed ID: 18565735
[TBL] [Abstract][Full Text] [Related]
16. Involvement of alphavbeta5 integrin in the establishment of autocrine TGF-beta signaling in dermal fibroblasts derived from localized scleroderma.
Asano Y; Ihn H; Jinnin M; Mimura Y; Tamaki K
J Invest Dermatol; 2006 Aug; 126(8):1761-9. PubMed ID: 16675963
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin G galactosylation levels are decreased in systemic sclerosis patients and differ according to disease subclassification.
Liu Q; Lin J; Han J; Zhang Y; Lu J; Tu W; Zhao Y; Guo G; Chu H; Pu W; Liu J; Ma Y; Chen X; Zhang R; Gu J; Zou H; Jin L; Wu W; Ren S; Wang J
Scand J Rheumatol; 2020 Mar; 49(2):146-153. PubMed ID: 31538512
[No Abstract] [Full Text] [Related]
18. Expression of CD1a and CD86 on scleroderma Langerhans cells.
Xie Y; Zhang X; Inoue Y; Wakasugi S; Makino T; Ihn H
Eur J Dermatol; 2008; 18(1):50-4. PubMed ID: 18086589
[TBL] [Abstract][Full Text] [Related]
19. Localized and systemic scleroderma show different histological responses to methotrexate therapy.
Seyger MM; van den Hoogen FH; van Vlijmen-Willems IM; van de Kerkhof PC; de Jong EM
J Pathol; 2001 Apr; 193(4):511-6. PubMed ID: 11276011
[TBL] [Abstract][Full Text] [Related]
20. Systemic sclerosis: Is the epithelium a missing piece of the pathogenic puzzle?
Asano Y; Takahashi T; Saigusa R
J Dermatol Sci; 2019 May; 94(2):259-265. PubMed ID: 31079997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
